{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:31:29Z","timestamp":1790652689089,"version":"4.1.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"30","license":[{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Concerns have been raised about allergic reactions to messenger ribonucleic acid (mRNA) coronavirus disease 2019 (COVID-19) vaccines. A history of allergic reactions, including anaphylaxis to drugs, has been frequently reported in individuals with anaphylaxis to mRNA vaccines.<\/jats:p>\n          <jats:p>To estimate the rate of immediate allergic reactions in patients with a history of drug allergy or other allergic disorders.<\/jats:p>\n          <jats:p>We included adult patients who had received at least 1 dose of an mRNA COVID-19 vaccine at the Special Hospital for Pulmonary Diseases between March 1, 2021, and October 1, 2021, and who reported a history of drug allergy or other allergic diseases (asthma, allergic rhinitis, atopic dermatitis, food or insect venom allergy, mastocytosis, idiopathic anaphylaxis, acute or chronic urticaria, and\/or angioedema). Immediate allergic reactions, including anaphylaxis, occurring within 4 hours of vaccination were recorded.<\/jats:p>\n          <jats:p>Six immediate allergic reactions were noted in the cohort of 1679 patients (0.36%). One patient experienced anaphylaxis (0.06%), which resolved after epinephrine administration, and the other reactions were mild and easily treatable.<\/jats:p>\n          <jats:p>Most patients with a history of allergies can safely receive an mRNA COVID-19 vaccine, providing adequate observation periods and preparedness to recognize and treat anaphylaxis.<\/jats:p>","DOI":"10.1097\/md.0000000000029571","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T22:01:33Z","timestamp":1660168893000},"page":"e29571","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Incidence of immediate allergic reactions to mRNA COVID-19 vaccines in adults with drug allergies and other allergic disorders"],"prefix":"10.1097","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6042-5607","authenticated-orcid":false,"given":"Ivan","family":"Markovi\u0107","sequence":"first","affiliation":[{"name":"Special Hospital for Pulmonary Diseases, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Bo\u017ean","sequence":"additional","affiliation":[{"name":"Special Hospital for Pulmonary Diseases, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomislav","family":"Perkovi\u0107","sequence":"additional","affiliation":[{"name":"Special Hospital for Pulmonary Diseases, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Pau\u0161ek","sequence":"additional","affiliation":[{"name":"Special Hospital for Pulmonary Diseases, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanja","family":"Nedeljkovi\u0107","sequence":"additional","affiliation":[{"name":"Special Hospital for Pulmonary Diseases, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Perkovi\u0107","sequence":"additional","affiliation":[{"name":"Special Hospital for Pulmonary Diseases, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomislav","family":"Kelava","sequence":"additional","affiliation":[{"name":"Department of Physiology and Immunology, University of Zagreb, School of Medicine, Zagreb, Croatia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinko","family":"Artukovi\u0107","sequence":"additional","affiliation":[{"name":"Special Hospital for Pulmonary Diseases, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asja","family":"Stipi\u0107 Markovi\u0107","sequence":"additional","affiliation":[{"name":"Special Hospital for Pulmonary Diseases, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,7,29]]},"reference":[{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jaci.2015.07.048","article-title":"Risk of anaphylaxis after vaccination in children and adults.","volume":"137","author":"McNeil","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"46","DOI":"10.15585\/mmwr.mm7002e1","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.","volume":"70","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"125","DOI":"10.15585\/mmwr.mm7004e1","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 Vaccine\u2014United States, December 21, 2020-January 10, 2021.","volume":"70","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/jama.2021.1967","article-title":"Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US-December 14, 2020-January 18, 2021.","volume":"325","author":"Shimabukuro","year":"2021","journal-title":"JAMA"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.vaccine.2021.11.066","article-title":"Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines.","volume":"40","author":"Maltezou","year":"2022","journal-title":"Vaccine"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1016\/j.jaip.2021.06.006","article-title":"The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and international consensus approach.","volume":"9","author":"Greenhawt","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"e2125524","DOI":"10.1001\/jamanetworkopen.2021.25524","article-title":"Assessment of allergic and anaphylactic reactions to mRNA COVID-19 vaccines with confirmatory testing in a US regional health system.","volume":"4","author":"Warren","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1016\/j.vaccine.2021.06.058","article-title":"Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration.","volume":"39","author":"Desai","year":"2021","journal-title":"Vaccine"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1473-3099(13)70324-4","article-title":"Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statement.","volume":"14","author":"Field","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"100472","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World allergy organization anaphylaxis guidance 2020.","volume":"13","author":"Cardona","year":"2020","journal-title":"World Allergy Organ J"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.","volume":"25","author":"R\u00fcggeberg","year":"2007","journal-title":"Vaccine"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1001\/jama.2021.3976","article-title":"Acute allergic reactions to mRNA COVID-19 vaccines.","volume":"325","author":"Blumenthal","year":"2021","journal-title":"JAMA"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.jaip.2021.04.025","article-title":"Ascertainment bias in anaphylaxis safety data of COVID-19 vaccines.","volume":"9","author":"Hourihane","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jaip.2021.12.021","article-title":"Population-based incidence, severity, and risk factors associated with treated acute-onset COVID-19 mRNA vaccination-associated hypersensitivity reactions.","volume":"10","author":"Macy","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"e2131034e2131034","DOI":"10.1001\/jamanetworkopen.2021.31034","article-title":"Association of self-reported high-risk allergy history with allergy symptoms after COVID-19 vaccination.","volume":"4","author":"Li","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"e2122255","DOI":"10.1001\/jamanetworkopen.2021.22255","article-title":"Prevalence of allergic reactions after Pfizer-BioNTech COVID-19 vaccination among adults with high allergy risk.","volume":"4","author":"Shavit","year":"2021","journal-title":"JAMA Netw Open"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:11:50Z","timestamp":1746331910000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":17,"journal-issue":{"issue":"30","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029571","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,29]]}}}